We have qualitatively reviewed this strategy and reaffirmed its Above Average Process and People ratings. Vanguard Value constructs a well-diversified, market-cap-weighted basket of U.S. value stocks at a rock-bottom fee, a recipe for success over the long run. The following text is from April 10, 2023.
Vanguard Value Index Inv VIVAX
- NAV / 1-Day Return 62.56 / −0.14 %
- Total Assets 168.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.170%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 3,000
- Status Limited
- TTM Yield 2.34%
- Turnover 10%
USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:22 PM GMT+0
Morningstar’s Analysis VIVAX
Will VIVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Berkshire Hathaway Inc Class B | 3.19 | 5.4 Bil | Financial Services |
Broadcom Inc | 3.07 | 5.2 Bil | Technology |
JPMorgan Chase & Co | 2.88 | 4.9 Bil | Financial Services |
Exxon Mobil Corp | 2.60 | 4.4 Bil | Energy |
UnitedHealth Group Inc | 2.26 | 3.8 Bil | Healthcare |
Procter & Gamble Co | 1.91 | 3.2 Bil | Consumer Defensive |
Johnson & Johnson | 1.74 | 2.9 Bil | Healthcare |
The Home Depot Inc | 1.65 | 2.8 Bil | Consumer Cyclical |
Merck & Co Inc | 1.57 | 2.6 Bil | Healthcare |
Walmart Inc | 1.44 | 2.4 Bil | Consumer Defensive |